DK2448968T3 - ANTISTOFFER SOM ER SELEKTIVE FOR N-TERMINAL-TRUNKEREDE AMYLOID-ß PROTOFIBRILLER/OLIGOMERER - Google Patents
ANTISTOFFER SOM ER SELEKTIVE FOR N-TERMINAL-TRUNKEREDE AMYLOID-ß PROTOFIBRILLER/OLIGOMERER Download PDFInfo
- Publication number
- DK2448968T3 DK2448968T3 DK10739701.0T DK10739701T DK2448968T3 DK 2448968 T3 DK2448968 T3 DK 2448968T3 DK 10739701 T DK10739701 T DK 10739701T DK 2448968 T3 DK2448968 T3 DK 2448968T3
- Authority
- DK
- Denmark
- Prior art keywords
- protofibrills
- trunked
- amyloid
- oligomers
- terminal
- Prior art date
Links
- 102000013455 Amyloid beta-Peptides Human genes 0.000 title 1
- 108010090849 Amyloid beta-Peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22110509P | 2009-06-29 | 2009-06-29 | |
| PCT/IB2010/052947 WO2011001366A1 (en) | 2009-06-29 | 2010-06-29 | N-terminal truncated amyloid beta protofibrils/ oligomers for use in therapeutic and diagnostic methods for alzheimer's disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2448968T3 true DK2448968T3 (da) | 2021-04-12 |
Family
ID=42832352
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK10739701.0T DK2448968T3 (da) | 2009-06-29 | 2010-06-29 | ANTISTOFFER SOM ER SELEKTIVE FOR N-TERMINAL-TRUNKEREDE AMYLOID-ß PROTOFIBRILLER/OLIGOMERER |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20120100129A1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP3892633A1 (cg-RX-API-DMAC7.html) |
| JP (3) | JP2012532094A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2010267640B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2765602C (cg-RX-API-DMAC7.html) |
| CY (1) | CY1124034T1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK2448968T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2864049T3 (cg-RX-API-DMAC7.html) |
| HR (1) | HRP20210611T1 (cg-RX-API-DMAC7.html) |
| HU (1) | HUE053949T2 (cg-RX-API-DMAC7.html) |
| LT (1) | LT2448968T (cg-RX-API-DMAC7.html) |
| PL (1) | PL2448968T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT2448968T (cg-RX-API-DMAC7.html) |
| SI (1) | SI2448968T1 (cg-RX-API-DMAC7.html) |
| SM (1) | SMT202100237T1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2011001366A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0401601D0 (sv) | 2004-06-21 | 2004-06-21 | Bioarctic Neuroscience Ab | Protofibril specific antibodies and uses thereof |
| EP2325209A3 (en) | 2006-03-23 | 2011-08-03 | BioArtic Neuroscience AB | Improved protofibril selective antibodies and the use thereof |
| ES2661925T3 (es) | 2010-02-26 | 2018-04-04 | Bioarctic Ab | Anticuerpos de unión a las protofibrillas y su uso en métodos terapéuticos diagnósticos para la enfermedad de Parkinson, la demencia con cuerpos de Lewy y otras alfa-sinucleinopatías |
| AU2012228236B2 (en) * | 2011-03-16 | 2016-10-27 | Vivoryon Therapeutics N.V. | Diagnostic antibody assay |
| JO3537B1 (ar) | 2014-07-10 | 2020-07-05 | Bioarctic Neuroscience Ab | أجسام مضادة لييفية أولية لاميلويد بيتا الببتيد ab المحسنة |
| US11327080B2 (en) | 2015-07-21 | 2022-05-10 | BioArctic Neruoscience AB | Method for treatment of traumatic brain injury targeting aggregated peptides |
| SG10201912842VA (en) | 2016-07-14 | 2020-02-27 | Bioarctic Ab | Brain delivery protein |
| AU2018308088B2 (en) | 2017-07-25 | 2025-05-29 | Truebinding, Inc. | Treating cancer by blocking the interaction of TIM-3 and its ligand |
| AU2019309938A1 (en) | 2018-07-24 | 2021-03-11 | Eisai R&D Management Co., Ltd. | Methods of treatment and prevention of alzheimer's disease |
| CA3127113A1 (en) | 2019-01-30 | 2020-08-06 | Dongxu Sun | Anti-gal3 antibodies and uses thereof |
| EP3998280A4 (en) * | 2019-07-08 | 2023-06-21 | TERUMO Kabushiki Kaisha | HYBRIDOME AND METHOD FOR PRODUCTION, MONOCLONAL ANTIBODY AND METHOD FOR PRODUCTION |
| US12352719B2 (en) | 2019-09-20 | 2025-07-08 | KYCERA AVX Components Corporation | Somatic cell-based electrical biosensor |
| AU2021278935A1 (en) | 2020-05-26 | 2022-12-08 | Truebinding, Inc. | Methods of treating inflammatory diseases by blocking Galectin-3 |
| PH12022552829A1 (en) | 2020-06-26 | 2023-06-14 | Bioarctic Ab | Alpha-synuclein protofibril-binding antibodies |
| JP2024525559A (ja) | 2021-07-09 | 2024-07-12 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | アルツハイマー病治療用バイオマーカー |
| WO2023034230A1 (en) | 2021-08-30 | 2023-03-09 | Eisai R&D Mangement Co., Ltd. | Subcutaneous formulations of anti-abeta protofibril antibody and methods of use thereof |
| AU2022439338A1 (en) | 2022-02-02 | 2024-08-15 | Eisai R&D Management Co., Ltd. | Methods of treatment using p-tau181 level |
| AU2023410175A1 (en) | 2022-12-22 | 2025-07-03 | Bioarctic Ab | Antibody which binds to abetape3 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5604102A (en) | 1992-04-15 | 1997-02-18 | Athena Neurosciences, Inc. | Methods of screening for β-amyloid peptide production inhibitors |
| DE60016227T2 (de) * | 1999-08-04 | 2005-12-15 | Northwestern University, Evanston | Globularer aufbau vom amyloid-beta- protein und deren verwendungen |
| EP1309341A2 (en) * | 2000-07-07 | 2003-05-14 | Lars Lannfelt | Prevention and treatment of alzheimer's disease |
| US7122374B1 (en) * | 2002-04-09 | 2006-10-17 | Takaomi Saido | Amyloid beta-protein 3(pE)-42 antibodies and uses thereof |
| EP1523499A2 (en) * | 2002-07-24 | 2005-04-20 | Innogenetics N.V. | Fragments of beta-amyloid as targets for vaccination against alzheimer disease |
| JP4633788B2 (ja) * | 2004-04-13 | 2011-02-16 | エフ．ホフマン−ラ ロシュ アーゲー | 抗ｐ−セレクチン抗体 |
| GB0413726D0 (en) * | 2004-06-18 | 2004-07-21 | Lauras As | Compounds |
| SE0401601D0 (sv) * | 2004-06-21 | 2004-06-21 | Bioarctic Neuroscience Ab | Protofibril specific antibodies and uses thereof |
| TWI355389B (en) * | 2004-07-30 | 2012-01-01 | Rinat Neuroscience Corp | Antibodies directed against amyloid-beta peptide a |
| EP2325209A3 (en) * | 2006-03-23 | 2011-08-03 | BioArtic Neuroscience AB | Improved protofibril selective antibodies and the use thereof |
| PT2207568T (pt) * | 2007-11-16 | 2017-09-01 | Univ Rockefeller | Anticorpos específicos para a forma de protofibrilha da proteína beta-amilóide |
| EP3470079A1 (en) * | 2008-04-29 | 2019-04-17 | BioArctic AB | Antibodies and vaccines for use in therapeutic and diagnostic methods for alpha-synuclein-related disorders |
-
2010
- 2010-06-29 DK DK10739701.0T patent/DK2448968T3/da active
- 2010-06-29 WO PCT/IB2010/052947 patent/WO2011001366A1/en not_active Ceased
- 2010-06-29 CA CA2765602A patent/CA2765602C/en active Active
- 2010-06-29 HU HUE10739701A patent/HUE053949T2/hu unknown
- 2010-06-29 EP EP21153326.0A patent/EP3892633A1/en active Pending
- 2010-06-29 EP EP10739701.0A patent/EP2448968B1/en active Active
- 2010-06-29 PT PT107397010T patent/PT2448968T/pt unknown
- 2010-06-29 US US13/379,523 patent/US20120100129A1/en not_active Abandoned
- 2010-06-29 AU AU2010267640A patent/AU2010267640B2/en active Active
- 2010-06-29 SM SM20210237T patent/SMT202100237T1/it unknown
- 2010-06-29 PL PL10739701T patent/PL2448968T3/pl unknown
- 2010-06-29 HR HRP20210611TT patent/HRP20210611T1/hr unknown
- 2010-06-29 ES ES10739701T patent/ES2864049T3/es active Active
- 2010-06-29 LT LTEP10739701.0T patent/LT2448968T/lt unknown
- 2010-06-29 JP JP2012516964A patent/JP2012532094A/ja not_active Withdrawn
- 2010-06-29 SI SI201032068T patent/SI2448968T1/sl unknown
-
2017
- 2017-04-19 JP JP2017083057A patent/JP6884025B2/ja active Active
-
2019
- 2019-08-01 JP JP2019142344A patent/JP2019218362A/ja active Pending
-
2021
- 2021-04-27 CY CY20211100361T patent/CY1124034T1/el unknown
-
2022
- 2022-12-15 US US18/066,998 patent/US20230295283A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2011001366A1 (en) | 2011-01-06 |
| AU2010267640A1 (en) | 2012-01-19 |
| JP2017197531A (ja) | 2017-11-02 |
| SMT202100237T1 (it) | 2021-05-07 |
| EP2448968B1 (en) | 2021-01-27 |
| JP6884025B2 (ja) | 2021-06-09 |
| CY1124034T1 (el) | 2022-05-27 |
| ES2864049T3 (es) | 2021-10-13 |
| EP2448968A1 (en) | 2012-05-09 |
| JP2019218362A (ja) | 2019-12-26 |
| CA2765602C (en) | 2021-05-25 |
| PL2448968T3 (pl) | 2021-09-13 |
| SI2448968T1 (sl) | 2021-07-30 |
| CA2765602A1 (en) | 2011-01-06 |
| EP3892633A1 (en) | 2021-10-13 |
| US20120100129A1 (en) | 2012-04-26 |
| HRP20210611T1 (hr) | 2021-05-28 |
| PT2448968T (pt) | 2021-04-30 |
| JP2012532094A (ja) | 2012-12-13 |
| AU2010267640B2 (en) | 2015-03-05 |
| US20230295283A1 (en) | 2023-09-21 |
| HUE053949T2 (hu) | 2021-08-30 |
| LT2448968T (lt) | 2021-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2448968T3 (da) | ANTISTOFFER SOM ER SELEKTIVE FOR N-TERMINAL-TRUNKEREDE AMYLOID-ß PROTOFIBRILLER/OLIGOMERER | |
| PT2406284T (pt) | Anticorpos anti-bcma | |
| BRPI1014262A2 (pt) | anticorpos específicos para caderina-17 | |
| ITPD20090053U1 (it) | Paradordi per banchine | |
| ES1070076Y (es) | Soporte-inmovilizador para cerramientos de vidrio | |
| TH93312B (th) | ขวด | |
| CN301156156S (zh) | 瓶(09-120) | |
| CN301156155S (zh) | 瓶(09-300) | |
| ITMI20080090U1 (it) | Contenitore -espositore per bottiglie | |
| ES1071124Y (es) | Parapente para aeromodelismo | |
| UA19091S (uk) | Упаковка для яєць | |
| UA20820S (uk) | Упакування для яєць | |
| ES1070987Y (es) | Agrupador para botellas | |
| UA19340S (uk) | Упаковка для вермішелі | |
| TH93146B (th) | ขวด | |
| CN301360184S (zh) | 瓶 | |
| UA19177S (uk) | Пляшка | |
| UA19054S (uk) | Пляшка | |
| UA19418S (uk) | Пляшка | |
| UA19328S (uk) | Пляшка | |
| UA19316S (uk) | Пляшка | |
| UA19244S (uk) | Пляшка | |
| UA19182S (uk) | Пляшка | |
| UA19464S (uk) | Пляшка | |
| UA19176S (uk) | Пляшка |